Skip to main content

Table 5 Univariate and multiple stepwise linear regression analysis for analyzing glucolipid metabolism associated with complications

From: Characteristics of glucolipid metabolism and complications in novel cluster-based diabetes subgroups: a retrospective study

Variables

Univariate

Multivariate

OR(95%CI)

P

OR(95%CI)

P

NAFLD

 HDL(mmol/L)

0.751(0.540 ~ 1.046)

0.091

  

 MHR

2.749(1.012 ~ 7.555)

0.049

  

 TG/HDL

1.239(1.121 ~ 1.371)

0.000

  

 FPG(mmol/L)

1.005(0.963 ~ 1.047)

0.833

  

 HbA1C(%)

1.046(0.977 ~ 1.120)

0.200

  

 FINS(mU/L)

1.123(1.082 ~ 1.165)

0.000

1.043(1.006 ~ 1.081)

0.021

 FCP(ng/ml)

3.331(2.466 ~ 4.500)

0.000

2.881(2.041 ~ 4.066)

 < 0.001

 HOMA2-β

1.004(0.998 ~ 1.010)

0.215

  

 HOMA2-IR

1.669(1.378 ~ 2.022)

0.000

  

 2hINS(mU/L)

1.007(1.002 ~ 1.013)

0.012

  

 2hCP(ng/ml)

1.109(1.035 ~ 1.189)

0.003

  

 2hPG(mmol/L)

1.013(0.983 ~ 1.044)

0.402

  

 TC(mmol/L)

1.260(1.079 ~ 1.471)

0.003

  

 TG(mmol/L)

1.288(1.145 ~ 1.449)

0.000

  

 TyG

1.677(1.344 ~ 2.093)

0.000

1.649(1.292 ~ 2.104)

 < 0.001

 LDL(mmol/L)

1.290(1.064 ~ 1.564)

0.010

  

ASCVD

 HDL(mmol/L)

0.949(0.480 ~ 1.875)

0.880

  

 MHR

0.865(0.121 ~ 6.155)

0.884

  

 TG/HDL

0.872(0.711 ~ 1.068)

0.185

  

 FPG(mmol/L)

0.911(0.829 ~ 1.002)

0.055

  

 HbA1C(%)

0.849(0.733 ~ 0.984)

0.030

  

 FINS(mU/L)

1.032(0.996 ~ 1.070)

0.080

  

 FCP(ng/ml)

1.578(1.051 ~ 2.370)

0.028

  

 HOMA2-β

1.014(1.005 ~ 1.023)

0.003

  

 HOMA2-IR

1.164(0.930 ~ 1.456)

0.185

  

 2hINS(mU/L)

1.015(1.008 ~ 1.022)

0.000

1.015(1.008 ~ 1.022)

 < 0.001

 2hCP(ng/ml)

1.218(1.109 ~ 1.338)

0.000

  

 2hPG(mmol/L)

1.009(0.952 ~ 1.069)

0.769

  

 TC(mmol/L)

0.866(0.637 ~ 1.176)

0.357

  

 TG(mmol/L)

0.833(0.650 ~ 1.069)

0.769

  

 TyG

0.700(0.565 ~ 1.080)

0.107

  

 LDL(mmol/L)

0.942(0.648 ~ 1.370)

0.755

  

CKD

 HDL(mmol/L)

0.832(0.597 ~ 1.162)

0.281

  

 MHR

1.044(0.399 ~ 2.732)

0.929

  

 TG/HDL

1.030(0.980 ~ 1.082)

0.251

  

 FPG(mmol/L)

1.013(0.972 ~ 1.056)

0.536

  

 HbA1C(%)

1.028(0.962 ~ 1.100)

0.414

  

 FINS(mU/L)

1.018(0.994 ~ 1.042)

0.153

  

 FCP(ng/ml)

1.297(1.027 ~ 1.637)

0.029

1.297(1.027 ~ 1.637)

0.029

 HOMA2-β

0.998(0.992 ~ 1.004)

0.492

  

 HOMA2-IR

1.113(0.971 ~ 1.276)

0.123

  

 2hINS(mU/L)

1.001(0.996 ~ 1.006)

0.616

  

 2hCP(ng/ml)

0.982(0.924 ~ 1.044)

0.563

  

 2hPG(mmol/L)

1.007(0.978 ~ 1.037)

0.651

  

 TC(mmol/L)

1.001(0.868 ~ 1.155)

0.987

  

 TG(mmol/L)

1.055(0.981 ~ 1.134)

0.147

  

 TyG

1.221(0.997 ~ 1.494)

0.054

  

 LDL(mmol/L)

1.011(0.841 ~ 1.215)

0.906

  
  1. Abbreviations: TC total cholesterol, TG triglycerides, LDL low-density lipoprotein, HDL high-density lipoprotein, TyG triglyceride glucose index, TG/HDL triglycerides to high-density lipoprotein ratio, MHR monocyte-to-high-density lipoprotein cholesterol ratio, HbA1C glycated hemoglobin, FPG fasting plasma glucose, FINS fasting insulin, FCP fasting C-peptide, 2hPG 2-h postprandial plasma glucose, 2hINS 2-h postprandial insulin, 2hCP 2-h postprandial C-peptide, DPN diabetic peripheral neuropathy, DR diabetic retinopathy, NAFLD non-alcohol Fatty Liver Disease, ASCVD arteriosclerotic cardiovascular disease, CKD chronic kidney disease, PVD peripheral vascular disease